Durability and Cross-Reactivity of SARS-CoV-2 mRNA Vaccine in Adolescent Children

Emergent SARS-CoV-2 variants and waning humoral immunity in vaccinated individuals have resulted in increased infections and hospitalizations. Children are not spared from infection nor complications of COVID-19, and the recent recommendation for boosters in individuals ages 12 years or older calls...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Madeleine D. Burns, Brittany P. Boribong, Yannic C. Bartsch, Maggie Loiselle, Kerri J. St. Denis, Maegan L. Sheehan, Jessica W. Chen, Jameson P. Davis, Rosiane Lima, Andrea G. Edlow, Alessio Fasano, Alejandro B. Balazs, Galit Alter, Lael M. Yonker
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI AG 2022-03-01
Colección:Vaccines
Materias:
SARS-CoV-2
COVID-19
pediatrics
adolescents
vaccines
boosters
Acceso en línea:https://www.mdpi.com/2076-393X/10/4/492
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares